- Meeting abstract
- Open Access
Brompton and Harefield Infection Score (BHIS): A novel scoring system for detection and treatment of sternal wound infection.
© Cannoletta et al. 2015
- Published: 16 December 2015
- Risk Group
- Score Risk
- High Risk Group
- Negative Pressure
- Healthcare Cost
Sternal wound infection (SWI) is a significant complication that increases risk of mortality, prolongs hospital stay, and increases healthcare cost. In our institution, we developed a novel scoring system (Brompton & Harefield Infection Score - BHIS) to identify patients at high risk of developing SWI following cardiac surgery with sternotomy. Patients identified to have high BHIS score was then treated with prophylactic intervention package.
We report our results of this novel intervention.
The BHIS score is scored based on variables including female gender (2), diabetes (1) or HbA1c =>7.5 (3), BMI >35 (2) and LVEF <45% (1). Patients were stratified into low risk (BHIS score 0-1), medium risk (BHIS score 2-3) and high risk (BHIS score 4 and above).
An intervention package was then developed for patients identified to have high BHIS score risk. The intervention package includes extended antimicrobial prophylaxis, standardized sternal closure, support wear (females), negative pressure dressing and patient education.
Data was collected between November 2013 and May 2015. During this period, 811 patients underwent cardiac surgery requiring sternotomy. In the low risk group, 9 patients out of 542 patients (SWI rate 1.7 per 100 operations) developed SWI. In the medium risk group, 7 patients out of 210 patients (SWI rate 3.3 per 100 operations) developed SWI. In the high risk group (59 patients), 20 patients received prophylactic intervention. In this group, there was no SWI, whereas in the 39 patients who did not receive prophylactic intervention, there was 5 SWI (SWI rate 12.8 per 100 operations).
The BHIS score is a novel scoring system for identifying patients at high risk of SWI. Patients identified to have high BHIS score and subsequently treated with prophylactic intervention are found to have reduced SWI rate.
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.